104 related articles for article (PubMed ID: 173189)
1. The ultrastructural response of human endometrium to medroxyprogesterone acetate.
Roberts DK; Horbelt DV; Powell LC
Am J Obstet Gynecol; 1975 Dec; 123(8):811-8. PubMed ID: 173189
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive and endometrial effects of medroxyprogesterone acetate.
Lee RA
Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
[TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17 beta-hydroxysteroid dehydrogenase activity, and serum hormone concentrations.
Kokko E; Jänne O; Kauppila A; Vihko R
Am J Obstet Gynecol; 1982 Jun; 143(4):382-8. PubMed ID: 6211985
[No Abstract] [Full Text] [Related]
4. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
Parkington HC; Lipton A
J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
[TBL] [Abstract][Full Text] [Related]
5. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study.
Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145
[TBL] [Abstract][Full Text] [Related]
6. A preliminary pharmacological trial of the monthly injectable contraceptive cycloprovera.
Fotherby K; Benagiano G; Toppozada HK; Abdel-Rahman A; Navaroli F; Arce B; Ramos-Cordero R; Gual C; Landgren BM; Johannisson E
Contraception; 1982 Mar; 25(3):261-72. PubMed ID: 6210485
[TBL] [Abstract][Full Text] [Related]
7. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
8. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
9. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
10. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
Lemay A; Jean C; Faure N
Fertil Steril; 1987 Nov; 48(5):775-82. PubMed ID: 2959569
[TBL] [Abstract][Full Text] [Related]
11. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
Saleh FM
Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
[TBL] [Abstract][Full Text] [Related]
12. Effect of nor-ethisterone enanthate (SH 393) on the structure of the endometrium and on the cervical mucus.
Achari K
J Obstet Gynaecol India; 1969; 19(6):731-6. PubMed ID: 12255497
[TBL] [Abstract][Full Text] [Related]
13. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels.
Frick J; Bartsch G; Weiske WH
Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
15. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
Nilsson O; Nygren KG
Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of medroxyprogesterone acetate (MPA) and megestrol acetate (MGA) on rat testicular steroidogenesis.
Barbieri RL; Ryan KJ
Acta Endocrinol (Copenh); 1980 Jul; 94(3):419-25. PubMed ID: 6968496
[TBL] [Abstract][Full Text] [Related]
18. Estrogenic activity in women receiving an injectable progestogen for contraception.
Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
[TBL] [Abstract][Full Text] [Related]
19. Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy.
Turner SJ; Mizock GB; Feldman GL
Am J Obstet Gynecol; 1966 May; 95(2):222-7. PubMed ID: 5935707
[TBL] [Abstract][Full Text] [Related]
20. After-effect of injection.
Nelson M
Vet Rec; 1977 Jan; 100(4):78. PubMed ID: 835219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
